Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Down 96.0% in June

Basel Medical Group Ltd (NASDAQ:BMGL) was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 12,662 shares, a decline of 96.0% from the June 15th total of 314,368 shares. Based on an average daily trading volume, of 12,536 shares, the short-interest ratio is presently 1.0 days. Approximately 0.8% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, June 30th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Hedge Funds Weigh In On Basel Medical Group

Institutional investors have recently bought and sold shares of the company. Citadel Advisors LLC purchased a new stake in Basel Medical Group in the third quarter worth $169,000. Virtu Financial LLC grew its stake in shares of Basel Medical Group by 108.8% during the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after acquiring an additional 17,608 shares during the period. Finally, Marex Group plc bought a new position in shares of Basel Medical Group during the 2nd quarter worth $25,000.

Basel Medical Group Stock Down 0.2%

BMGL traded down $0.01 during trading on Friday, hitting $6.61. 6,461 shares of the company traded hands, compared to its average volume of 22,474. Basel Medical Group has a one year low of $4.60 and a one year high of $54.60. The stock’s fifty day moving average is $7.38 and its 200 day moving average is $7.59. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.88 and a quick ratio of 1.83.

Basel Medical Group (NASDAQ:BMGL) last announced its quarterly earnings data on Friday, June 26th. The company reported $0.01 EPS for the quarter. The company had revenue of $3.21 million during the quarter.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.